For passers-by, the company will be combining Dr Perin's data in class 2 and 3 patients with separate data from a randomized trial in patients with end-stage CHF (ie class 4). Upcoming meeting with the FDA. Accelerated approval for HFrEF or a major partnership announcement are possible. The company has all rights (ex-China where there's an existing partnership). This is all separate from the BLA re-submission for GvHD announced yesterday. So, two imminent shots on goal with the FDA.
Aloha.
- Forums
- ASX - By Stock
- MSB
- DREAM HF Trial Video
DREAM HF Trial Video, page-61
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
0.008(0.64%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $1.748M | 1.492M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 61024 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 11519 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 63079 | 1.170 |
16 | 61793 | 1.165 |
15 | 103947 | 1.160 |
16 | 160071 | 1.155 |
18 | 600805 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.175 | 3126 | 4 |
1.180 | 106742 | 13 |
1.185 | 98273 | 12 |
1.190 | 169722 | 15 |
1.195 | 58421 | 6 |
Last trade - 12.00pm 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online